Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine in parkinsonism. A long-term study.

A J Lees, S Haddad, K M Shaw

    Archives of Neurology
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Charcot redux.

    Brain : a journal of neurology·2025
    Same author

    Charcot's interest in faith healing.

    Journal of the history of the neurosciences·2024
    Same author

    The Dopamine Dancer: The Value of Holistic Autotherapy in Parkinson's Disease.

    Movement disorders clinical practice·2024
    Same author

    Copper rings, blue moons and sunflower cataracts.

    Arquivos de neuro-psiquiatria·2024
    Same author

    Earworms-A Narrative Review of Infectious Music.

    JAMA·2024
    Same author

    Reduced to a number.

    Practical neurology·2023
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Bromocriptine showed benefit in some early Parkinson's disease patients, but offered limited advantages for those already treated with levodopa. Side effects were a significant issue for many participants.

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinson's disease is a progressive neurodegenerative disorder.
    • Levodopa is a primary treatment, but can cause motor complications.
    • Bromocriptine is a dopamine agonist investigated as an alternative or adjunct therapy.

    Purpose of the Study:

    • To evaluate the efficacy and safety of bromocriptine in Parkinson's disease patients.
    • To compare bromocriptine's effects in previously untreated patients versus those on levodopa.

    Main Methods:

    • A controlled trial involving 86 patients with Parkinson's disease.
    • Patients were categorized into: early/mild untreated, levodopa intolerant/non-responders, and those with residual disabilities on levodopa.
    • Treatment duration and patient outcomes, including motor fluctuations and dyskinesias, were monitored.

    Related Experiment Videos

    Main Results:

    • Eight of 30 untreated patients experienced sustained benefit for two years without "on-off" effects or dyskinesias.
    • Only two of 23 levodopa-intolerant patients benefited from bromocriptine.
    • Bromocriptine provided some benefit to 33 patients on levodopa, but side effects led to discontinuation; no improvement was seen in 11 patients with severe "on-off" disabilities.

    Conclusions:

    • Bromocriptine may benefit a subset of early Parkinson's disease patients.
    • It offers limited advantages for patients already on or intolerant to levodopa.
    • Unacceptable side effects limit bromocriptine's utility in advanced Parkinson's disease, despite comparable efficacy to levodopa at specific doses.